These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4380046)

  • 41. An inherited deficiency in noradrenaline biosynthesis in the brindled mouse.
    Hunt DM; Johnson DR
    J Neurochem; 1972 Dec; 19(12):2811-9. PubMed ID: 4405722
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of 6-hydroxydopamine on rat heart noradrenaline.
    Corrodi H; Masuoka DT; Clark WG
    Eur J Pharmacol; 1971 Jul; 15(2):160-3. PubMed ID: 5153842
    [No Abstract]   [Full Text] [Related]  

  • 43. [Radioautographic identification of dopaminergic axons in the rat CNS. In vitro marking with tritiated dopamine or noradenaline].
    Nguyen-Legros J; Berger B; Alvarez C
    C R Seances Acad Sci D; 1979 Dec; 289(16):1311-4. PubMed ID: 120791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues.
    Eisenhofer G; Hovevey-Sion D; Kopin IJ; Miletich R; Kirk KL; Finn R; Goldstein DS
    J Pharmacol Exp Ther; 1989 Jan; 248(1):419-27. PubMed ID: 2563292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dynamics of transmissional ultrastructures in sympathetic neurones on the rat.
    Taxi J
    J Neural Transm; 1974; Suppl 11(0):103-24. PubMed ID: 4153878
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of morphine and other centrally acting drugs on 3,4-dihydroxyphenylethylene glycol sulfate (DOPEG-SO4) in rat brain.
    Huff JW; Reigle TG
    Life Sci; 1980 Oct; 27(16):1483-8. PubMed ID: 7442455
    [No Abstract]   [Full Text] [Related]  

  • 47. Chronic treatment with desipramine caused a sustained decrease of 3,4-dihydroxyphenylglycol-sulphate and total 3-methoxy-4-hydroxyphenylglycol in the rat brain.
    Nielsen M; Braestrup C
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Oct; 300(1):87-92. PubMed ID: 593430
    [No Abstract]   [Full Text] [Related]  

  • 48. The relative role of storage and synthesis of brain norepinephrine in the psychomotor stimulation evoked by amphetamine or by desipramine and tetrabenazine.
    Sulser F; Owens ML; Norvich MR; Dingell JV
    Psychopharmacologia; 1968; 12(4):322-32. PubMed ID: 5652215
    [No Abstract]   [Full Text] [Related]  

  • 49. The effects of antidepressants on the retention and metabolism of [3H]-norepinephrine in rat brain slices.
    Crews FT; Smith CB
    Neuropharmacology; 1981 Apr; 20(4):363-9. PubMed ID: 7290350
    [No Abstract]   [Full Text] [Related]  

  • 50. A daily rhythm in the rate of depletion of brain norepinephrine by reserpine.
    Black IB; Parker L; Axelrod J
    Biochem Pharmacol; 1969 Oct; 18(10):2688-91. PubMed ID: 5404003
    [No Abstract]   [Full Text] [Related]  

  • 51. Selective protection of serotonin stores against the action of reserpine by -methyl-5-hydroxytryptpohan pretreatment.
    Lahti RA; Platz PA
    Biochem Pharmacol; 1969 Oct; 18(10):2363-9. PubMed ID: 4397869
    [No Abstract]   [Full Text] [Related]  

  • 52. Action of reserpine in morphine-tolerant rats: absence of an antagonism of catecholamine depletion.
    Blosser JC; Catravas GN
    J Pharmacol Exp Ther; 1974 Nov; 191(2):284-9. PubMed ID: 4422904
    [No Abstract]   [Full Text] [Related]  

  • 53. Studies on the interaction between catecholamines and tyrosine aminotransferase in brain.
    Zigmond MJ; Wilson SP
    Biochem Pharmacol; 1973 Sep; 22(17):2151-63. PubMed ID: 4147420
    [No Abstract]   [Full Text] [Related]  

  • 54. The effects of disulfiram on the repletion of brain catecholamine stores.
    Goldstein M; Nakajima K
    Life Sci; 1966 Jun; 5(12):1133-8. PubMed ID: 5963538
    [No Abstract]   [Full Text] [Related]  

  • 55. Metatyrosine-induced reversal of the suppression of the conditioned avoidance response in reserpine-treated rats.
    Engel J
    Acta Pharmacol Toxicol (Copenh); 1971; 30(3):278-88. PubMed ID: 4945487
    [No Abstract]   [Full Text] [Related]  

  • 56. The role of dopamine in motor excitation of mice induced by brain catecholamine releasers.
    Graeff FG
    J Pharm Pharmacol; 1966 Sep; 18(9):627-8. PubMed ID: 4381952
    [No Abstract]   [Full Text] [Related]  

  • 57. The occurrence of tryptamine in rat brain and its pharmacological manipulation.
    Horn AS; Snodgrass SR
    Br J Pharmacol; 1973 Mar; 47(3):646P. PubMed ID: 4147196
    [No Abstract]   [Full Text] [Related]  

  • 58. Accumulation and metabolism of norepinephrine in rat hypothalamus after exhaustive stress.
    Stone EA
    J Neurochem; 1973 Sep; 21(3):589-601. PubMed ID: 4742139
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacological effects of imipramine and desmethylimipramine in developing rats.
    Lapin IP; Osipova SV; Uskova NV; Stabrovski EM
    Psychopharmacologia; 1969; 14(4):255-65. PubMed ID: 5350628
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of reserpine and desipramine on the uptake and subcellular distribution of 5-hydroxytryptamine in rabbit brain stem after intravenous administration of 5-hydroxytryptophan.
    Segawa T
    Jpn J Pharmacol; 1970 Mar; 20(1):87-91. PubMed ID: 4393817
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.